Abstract
Age-related macular degeneration (AMD) is one of the leading causes of irreversible blindness in the elderly, particularly in its dry form, which accounts for approximately 80 to 90% of cases and still lacks effective therapies. This project proposes the development of an oral formulation combining curcumin, propolis, zeaxanthin, and lutein, aiming to slow the progression of dry AMD. Prel…
